Skip to main content
Journal cover image

Designing preclinical perceptibility measures to evaluate topical vaginal gel formulations: relating user sensory perceptions and experiences to formulation properties.

Publication ,  Journal Article
Morrow, KM; Fava, JL; Rosen, RK; Vargas, S; Shaw, JG; Kojic, EM; Kiser, PF; Friend, DR; Katz, DF; Project Link Study Team,
Published in: AIDS research and human retroviruses
January 2014

Abstract The effectiveness of any biomedical prevention technology relies on both biological efficacy and behavioral adherence. Microbicide trials have been hampered by low adherence, limiting the ability to draw meaningful conclusions about product effectiveness. Central to this problem may be an inadequate conceptualization of how product properties themselves impact user experience and adherence. Our goal is to expand the current microbicide development framework to include product "perceptibility," the objective measurement of user sensory perceptions (i.e., sensations) and experiences of formulation performance during use. For vaginal gels, a set of biophysical properties, including rheological properties and measures of spreading and retention, may critically impact user experiences. Project LINK sought to characterize the user experience in this regard, and to validate measures of user sensory perceptions and experiences (USPEs) using four prototype topical vaginal gel formulations designed for pericoital use. Perceptibility scales captured a range of USPEs during the product application process (five scales), ambulation after product insertion (six scales), and during sexual activity (eight scales). Comparative statistical analyses provided empirical support for hypothesized relationships between gel properties, spreading performance, and the user experience. Project LINK provides preliminary evidence for the utility of evaluating USPEs, introducing a paradigm shift in the field of microbicide formulation design. We propose that these user sensory perceptions and experiences initiate cognitive processes in users resulting in product choice and willingness-to-use. By understanding the impact of USPEs on that process, formulation development can optimize both drug delivery and adherence.

Duke Scholars

Published In

AIDS research and human retroviruses

DOI

EISSN

1931-8405

ISSN

0889-2229

Publication Date

January 2014

Volume

30

Issue

1

Start / End Page

78 / 91

Related Subject Headings

  • Young Adult
  • Virology
  • Vaginal Creams, Foams, and Jellies
  • Vagina
  • Menstrual Cycle
  • Medication Adherence
  • Humans
  • HIV Infections
  • Female
  • Drug Delivery Systems
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Morrow, K. M., Fava, J. L., Rosen, R. K., Vargas, S., Shaw, J. G., Kojic, E. M., … Project Link Study Team, . (2014). Designing preclinical perceptibility measures to evaluate topical vaginal gel formulations: relating user sensory perceptions and experiences to formulation properties. AIDS Research and Human Retroviruses, 30(1), 78–91. https://doi.org/10.1089/aid.2013.0099
Morrow, Kathleen M., Joseph L. Fava, Rochelle K. Rosen, Sara Vargas, Julia G. Shaw, E Milu Kojic, Patrick F. Kiser, David R. Friend, David F. Katz, and David F. Project Link Study Team. “Designing preclinical perceptibility measures to evaluate topical vaginal gel formulations: relating user sensory perceptions and experiences to formulation properties.AIDS Research and Human Retroviruses 30, no. 1 (January 2014): 78–91. https://doi.org/10.1089/aid.2013.0099.
Morrow KM, Fava JL, Rosen RK, Vargas S, Shaw JG, Kojic EM, et al. Designing preclinical perceptibility measures to evaluate topical vaginal gel formulations: relating user sensory perceptions and experiences to formulation properties. AIDS research and human retroviruses. 2014 Jan;30(1):78–91.
Morrow, Kathleen M., et al. “Designing preclinical perceptibility measures to evaluate topical vaginal gel formulations: relating user sensory perceptions and experiences to formulation properties.AIDS Research and Human Retroviruses, vol. 30, no. 1, Jan. 2014, pp. 78–91. Epmc, doi:10.1089/aid.2013.0099.
Morrow KM, Fava JL, Rosen RK, Vargas S, Shaw JG, Kojic EM, Kiser PF, Friend DR, Katz DF, Project Link Study Team. Designing preclinical perceptibility measures to evaluate topical vaginal gel formulations: relating user sensory perceptions and experiences to formulation properties. AIDS research and human retroviruses. 2014 Jan;30(1):78–91.
Journal cover image

Published In

AIDS research and human retroviruses

DOI

EISSN

1931-8405

ISSN

0889-2229

Publication Date

January 2014

Volume

30

Issue

1

Start / End Page

78 / 91

Related Subject Headings

  • Young Adult
  • Virology
  • Vaginal Creams, Foams, and Jellies
  • Vagina
  • Menstrual Cycle
  • Medication Adherence
  • Humans
  • HIV Infections
  • Female
  • Drug Delivery Systems